alexa Kava as a Pharmacotherapy of Anxiety Disorders: Promise
ISSN: 2161-0444

Medicinal chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Kava as a Pharmacotherapy of Anxiety Disorders: Promises and Concerns

Zachary Rivers1, Chengguo Xing2 and Sreekanth Narayanapillai2*

1College of Pharmacy, University of Minnesota, 308 Harvard St SE, Minneapolis, MN 55455, USA

2Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, 2231 6th St SE, Minneapolis, MN 55455, USA

*Corresponding Author:
Sreekanth Narayanapillai
Department of Medicinal Chemistry, College of Pharmacy
University of Minnesota, 2231 6th St SE
Minneapolis,MN 55455, USA
Tel: 612-626-5543
E-mail: [email protected]

Received date: January 23, 2016; Accepted date: February 05, 2016; Published date: February 09, 2016

Citation: Rivers Z, Xing C, Narayanapillai S (2016) Kava as a Pharmacotherapy of Anxiety Disorders: Promises and Concerns. Med chem 6:081-087. doi:10.4172/2161-0444.1000329

Copyright: © 2016 Rivers Z, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

 

Current standard pharmacotherapies for anxiety management come with a host of side-effects that may deter the patients from utilizing them. Kava, a traditional beverage from the South Pacific region, has been used as a natural medicine for centuries and has been hypothesized to contain anxiolytic properties. There are a few well-designed, randomly controlled trials that have evaluated the effectiveness of kava or its constituents against anxiety disorders. They have generally shown kava to be effective in managing the disease. However, there has been a serious concern about the hepatotoxic risk of kava, which greatly limits its anxiolytic development and application. This review attempts to summarize the recent anxiolytic trials using kava, the associated hepatotoxicity risks, the potential responsible chemicals for these two activities, and the mechanisms of action. Overall, kava has a great potential to be developed as a natural anxiolytic agent through a systematic approach, but the present form should be used with caution.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords